Recro Pharma, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (29)

Latest Posts

About This Stock More About This Stock
Stock Charts To Watch - Thursday, January 9
Video By: Harry Boxer
Thursday, January 9, 2020 9:15 PM EDT
Amneal Pharmaceuticals, Inc. looks pretty good. It popped 17 cents, or 3.76%, to 4.69, with a high of 4.73, on 1.9 million shares on Thursday.
In this video: SONO, REPH, JNCE, IQ, SE, AMRX
Watch
A Quick Look At Recro Pharma
Article By: KKD Healthcare Analytics
Sunday, January 22, 2017 12:07 PM EDT
Recro Pharma develops non-opioid drugs for pain management. REPH is targeting an NDA this year for its fast-acting IV version of Meloxicam, a well-known NSAID whose oral version just takes too long to work, but has been shown to be effective.
In this article: REPH
Read
5 Best Performing Nasdaq Stocks Of 2015
Article By: Zacks Investment Research
Monday, December 28, 2015 12:18 PM EDT
In the countdown to 2016, U.S. stocks look to end a lackluster year on a disappointing note. We’ve selected five top Nasdaq performers of 2015.
In this article: EFOI, LPTH, EGRX, HQCL, REPH Also: ALXN, AAPL, AMGN, AMZN, BIIB, GILD, INTC, MSFT, MYL, NFLX, PRGO, TEVA
Read

Latest Tweets for $REPH

No tweets yet!